Sterling Global Strategies’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,429
Closed -$5.86K 206
2018
Q4
$5.86K Buy
+1,429
New +$7.46K 0.03% 170
2017
Q3
Sell
-2,857
Closed -$12K 34
2017
Q2
$12K Buy
2,857
+1,428
+100% +$5.85K 0.06% 24
2017
Q1
$7K Sell
1,429
-1,428
-50% -$4.79K 0.03% 29
2016
Q4
$6K Buy
2,857
+1,428
+100% +$3.34K 0.02% 27
2016
Q3
$4K Hold
1,429
0.01% 31
2016
Q2
$4K Hold
1,429
0.02% 25
2016
Q1
$4K Hold
1,429
0.02% 26
2015
Q4
$12K Buy
+1,429
New +$11.5K 0.19% 18
2015
Q3
Sell
-1,429
Closed -$13K 23
2015
Q2
$13K Hold
1,429
0.04% 21
2015
Q1
$14K Sell
1,429
-714
-33% -$6.87K 0.04% 24
2014
Q4
$21K Buy
+2,143
New +$21.6K 0.01% 23

Other funds holding CDMO

Sterling Global Strategies's CDMO Position: Q1 2019 in Review

Sterling Global Strategies sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2019, closing a stake of 1,429 shares — an estimated $5.86K sold.

Sterling Global Strategies first reported a position in CDMO in Q4 2014 and held it in 11 quarters. The position peaked at $21K in Q4 2014. 97 funds tracked by Wall St. Rank hold CDMO as of Q1 2019.

  • Sterling Global Strategies reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Sterling Global Strategies sold 1,429 Avid Bioservices, Inc. Common Stock shares in Q1 2019, an estimated $5.86K.
  • Sterling Global Strategies first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2014 and held it in 11 quarters.
  • Sterling Global Strategies's Avid Bioservices, Inc. Common Stock position peaked at $21K in Q4 2014.
  • 97 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2019.

Based on Sterling Global Strategies's 13F filing for Q1 2019, filed 15 May 2019.